BSX
Price
$97.92
Change
+$0.23 (+0.24%)
Updated
Sep 24, 11:49 AM (EDT)
Capitalization
144.75B
28 days until earnings call
DXCM
Price
$68.03
Change
-$0.17 (-0.25%)
Updated
Sep 24, 11:56 AM (EDT)
Capitalization
26.74B
29 days until earnings call
Interact to see
Advertisement

BSX vs DXCM

Header iconBSX vs DXCM Comparison
Open Charts BSX vs DXCMBanner chart's image
Boston Scientific
Price$97.92
Change+$0.23 (+0.24%)
Volume$3.68K
Capitalization144.75B
DexCom
Price$68.03
Change-$0.17 (-0.25%)
Volume$600
Capitalization26.74B
BSX vs DXCM Comparison Chart in %
Loading...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSX vs. DXCM commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a Hold and DXCM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (BSX: $97.69 vs. DXCM: $68.20)
Brand notoriety: BSX: Notable vs. DXCM: Not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BSX: 184% vs. DXCM: 133%
Market capitalization -- BSX: $144.75B vs. DXCM: $26.74B
BSX [@Medical/Nursing Services] is valued at $144.75B. DXCM’s [@Medical/Nursing Services] market capitalization is $26.74B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $236.51B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.53B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 1 FA rating(s) are green whileDXCM’s FA Score has 0 green FA rating(s).

  • BSX’s FA Score: 1 green, 4 red.
  • DXCM’s FA Score: 0 green, 5 red.
According to our system of comparison, DXCM is a better buy in the long-term than BSX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 5 TA indicator(s) are bullish while DXCM’s TA Score has 4 bullish TA indicator(s).

  • BSX’s TA Score: 5 bullish, 5 bearish.
  • DXCM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BSX is a better buy in the short-term than DXCM.

Price Growth

BSX (@Medical/Nursing Services) experienced а -1.30% price change this week, while DXCM (@Medical/Nursing Services) price change was -10.91% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.80%. For the same industry, the average monthly price growth was +5.63%, and the average quarterly price growth was +11.25%.

Reported Earning Dates

BSX is expected to report earnings on Oct 22, 2025.

DXCM is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Medical/Nursing Services (+1.80% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSX($145B) has a higher market cap than DXCM($26.7B). BSX has higher P/E ratio than DXCM: BSX (58.15) vs DXCM (48.03). BSX YTD gains are higher at: 9.371 vs. DXCM (-12.306). BSX has higher annual earnings (EBITDA): 4.65B vs. DXCM (1.04B). DXCM has more cash in the bank: 2.93B vs. BSX (534M). DXCM has less debt than BSX: DXCM (2.58B) vs BSX (12B). BSX has higher revenues than DXCM: BSX (18.5B) vs DXCM (4.3B).
BSXDXCMBSX / DXCM
Capitalization145B26.7B543%
EBITDA4.65B1.04B447%
Gain YTD9.371-12.306-76%
P/E Ratio58.1548.03121%
Revenue18.5B4.3B430%
Total Cash534M2.93B18%
Total Debt12B2.58B465%
FUNDAMENTALS RATINGS
BSX vs DXCM: Fundamental Ratings
BSX
DXCM
OUTLOOK RATING
1..100
5262
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
78
Overvalued
PROFIT vs RISK RATING
1..100
7100
SMR RATING
1..100
6441
PRICE GROWTH RATING
1..100
6164
P/E GROWTH RATING
1..100
6535
SEASONALITY SCORE
1..100
6550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DXCM's Valuation (78) in the Medical Specialties industry is in the same range as BSX (82). This means that DXCM’s stock grew similarly to BSX’s over the last 12 months.

BSX's Profit vs Risk Rating (7) in the Medical Specialties industry is significantly better than the same rating for DXCM (100). This means that BSX’s stock grew significantly faster than DXCM’s over the last 12 months.

DXCM's SMR Rating (41) in the Medical Specialties industry is in the same range as BSX (64). This means that DXCM’s stock grew similarly to BSX’s over the last 12 months.

BSX's Price Growth Rating (61) in the Medical Specialties industry is in the same range as DXCM (64). This means that BSX’s stock grew similarly to DXCM’s over the last 12 months.

DXCM's P/E Growth Rating (35) in the Medical Specialties industry is in the same range as BSX (65). This means that DXCM’s stock grew similarly to BSX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXDXCM
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
59%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bearish Trend 1 day ago
43%
Bearish Trend 1 day ago
60%
MACD
ODDS (%)
Bearish Trend 1 day ago
47%
Bearish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
43%
Bearish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
43%
Bearish Trend 1 day ago
70%
Advances
ODDS (%)
Bullish Trend 22 days ago
62%
Bullish Trend 21 days ago
71%
Declines
ODDS (%)
Bearish Trend 3 days ago
44%
Bearish Trend 6 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
65%
Aroon
ODDS (%)
Bullish Trend 1 day ago
56%
Bearish Trend 1 day ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FLRT47.580.01
+0.01%
Pacer Aristotle Pac Ast Fl Rt Hi Inc ETF
FPE18.39N/A
N/A
First Trust Preferred Sec & Inc ETF
HAPS31.38N/A
N/A
Harbor Human Capital Factor US Sm CapETF
HAIL36.03-0.19
-0.54%
SPDR® S&P Kensho Smart Mobility ETF
TTEQ32.18-0.31
-0.96%
T. Rowe Price Technology ETF

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been closely correlated with ISRG. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSX jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
+0.68%
ISRG - BSX
69%
Closely correlated
+0.72%
SYK - BSX
65%
Loosely correlated
-1.24%
MMSI - BSX
58%
Loosely correlated
+0.16%
PODD - BSX
49%
Loosely correlated
-2.18%
ALC - BSX
48%
Loosely correlated
-3.07%
More

DXCM and

Correlation & Price change

A.I.dvisor indicates that over the last year, DXCM has been loosely correlated with GKOS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DXCM jumps, then GKOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DXCM
1D Price
Change %
DXCM100%
-1.88%
GKOS - DXCM
46%
Loosely correlated
+0.08%
VAPO - DXCM
43%
Loosely correlated
N/A
BSX - DXCM
41%
Loosely correlated
+0.68%
PODD - DXCM
40%
Loosely correlated
-2.18%
RMD - DXCM
35%
Loosely correlated
+0.44%
More